Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.31
(-16.67%)
USD 0.31
(-16.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.48 Million USD | 80.59% |
| 2022 | -7.66 Million USD | -1717.48% |
| 2021 | 474.12 Thousand USD | -32.14% |
| 2020 | 698.66 Thousand USD | 0.0% |
| 2018 | 47.61 Thousand USD | -81.94% |
| 2017 | 263.66 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 459.75 Thousand USD | 503.03% |
| 2024 Q1 | -114.07 Thousand USD | 92.34% |
| 2023 Q1 | -5.61 Million USD | 26.77% |
| 2023 Q3 | -2.91 Million USD | 37.42% |
| 2023 FY | -1.48 Million USD | 80.59% |
| 2023 Q4 | -1.48 Million USD | 49.0% |
| 2023 Q2 | -4.66 Million USD | 16.93% |
| 2022 Q4 | -7.66 Million USD | 8.21% |
| 2022 FY | -7.66 Million USD | -1717.48% |
| 2022 Q2 | 1.3 Million USD | 59.54% |
| 2022 Q1 | 819.72 Thousand USD | 72.89% |
| 2022 Q3 | -8.35 Million USD | -738.83% |
| 2021 FY | 474.12 Thousand USD | -32.14% |
| 2021 Q4 | 474.12 Thousand USD | 0.0% |
| 2020 FY | 698.66 Thousand USD | 0.0% |
| 2018 FY | 47.61 Thousand USD | -81.94% |
| 2017 FY | 263.66 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 100.342% |
| Embecta Corp. | 1.31 Billion USD | 100.113% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 101.58% |
| Dynavax Technologies Corporation | 106.63 Million USD | 101.396% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 100.325% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 100.344% |
| PainReform Ltd. | -7.95 Million USD | 81.274% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 101.986% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 90.478% |
| SCYNEXIS, Inc. | -19.35 Million USD | 92.306% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 84.212% |
| Cosmos Health Inc. | 8.59 Million USD | 117.329% |
| Journey Medical Corporation | -9.7 Million USD | 84.667% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 90.478% |
| Safety Shot Inc | -2.28 Million USD | 34.83% |
| Alpha Teknova, Inc. | 1.97 Million USD | 175.417% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 98.862% |
| Bright Green Corporation | 1.84 Million USD | 180.833% |
| Procaps Group, S.A. | 242.93 Million USD | 100.613% |
| Theratechnologies Inc. | 24.87 Million USD | 105.986% |
| Harrow Health, Inc. | 116.41 Million USD | 101.279% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 40.924% |
| Biofrontera Inc. | 4.05 Million USD | 136.704% |
| DURECT Corporation | -7.65 Million USD | 80.55% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 95.56% |
| Cronos Group Inc. | -663.32 Million USD | 99.776% |
| OptiNose, Inc. | 58.06 Million USD | 102.564% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 100.239% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 89.784% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 71.294% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 109.916% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 76.591% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 1493.165% |
| Radius Health, Inc. | 359.28 Million USD | 100.414% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 854.896% |
| ProPhase Labs, Inc. | 19.23 Million USD | 107.741% |
| Phibro Animal Health Corporation | 454.84 Million USD | 100.327% |
| Procaps Group S.A. | 242.93 Million USD | 100.613% |
| Alvotech | 1.06 Billion USD | 100.14% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 140.476% |
| Viatris Inc. | 17.13 Billion USD | 100.009% |
| Rockwell Medical, Inc. | 4.45 Million USD | 133.409% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 69.475% |
| SIGA Technologies, Inc. | -148.68 Million USD | 98.999% |
| Tilray Brands, Inc. | 158.97 Million USD | 100.936% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 101.221% |
| Shineco, Inc. | 29.29 Million USD | 105.083% |
| PetIQ, Inc. | 351.93 Million USD | 100.423% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 48.69% |
| Incannex Healthcare Limited | -5.48 Million USD | 72.858% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 100.84% |
| Alimera Sciences, Inc. | 55.3 Million USD | 102.692% |
| Silver Spike Investment Corp. | -32.61 Million USD | 95.435% |
| Assertio Holdings, Inc. | -32.52 Million USD | 95.423% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 70.581% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 69.075% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 81.875% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 135.303% |
| Hempacco Co., Inc. | 13.61 Million USD | 110.935% |
| Talphera, Inc. | -5.72 Million USD | 73.978% |
| Alvotech | 1.06 Billion USD | 100.14% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 120.836% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 98.461% |
| Currenc Group, Inc. | -16.57 Million USD | 91.017% |
| Kamada Ltd. | -46.43 Million USD | 96.794% |
| Indivior PLC | -33.95 Million USD | 95.615% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 671.324% |
| Flora Growth Corp. | -713 Thousand USD | -108.797% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 81.875% |
| Evolus, Inc. | 63.7 Million USD | 102.337% |
| HUTCHMED (China) Limited | -197.45 Million USD | 99.246% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 100.311% |
| Akanda Corp. | 3.9 Million USD | 138.124% |